Bioventus Inc Share Price Today: Live Updates & Key Insights

Bioventus Inc share price today is $8.46, up -4%. The stock opened at $8.9 against the previous close of $9, with an intraday high of $8.9 and low of $8.47.

Bioventus Inc Share Price Chart

Bioventus Inc

us-stock
To Invest in {{usstockname}}
us-stock

Bioventus Inc Share Price Performance

$8.46 -0.04(-4%) BVS at 23 Mar 2026 12:20 PM Medical Devices
Lowest Today 8.47
Highest Today 8.9
Today’s Open 8.9
Prev. Close 9
52 Week High 9.98
52 Week Low 5.81
Day’s Range: Low 8.47 High 8.9
52-Week Range: Low 5.81 High 9.98
1 day return -
1 Week return -2.37
1 month return -
3 month return +15.71
6 month return +24.63
1 year return -11.0
3 year return +540.74
5 year return -44.22
10 year return -

Bioventus Inc Institutional Holdings

Essex Woodlands Health Ventures 19.33

Juniper Investment Co, LLC 10.30

Nantahala Capital Management, LLC 8.98

BlackRock Inc 4.56

Vanguard Group Inc 4.43

Royce & Associates, LP 1.86

Geode Capital Management, LLC 1.66

iShares Russell 2000 ETF 1.66

Vanguard Total Stock Mkt Idx Inv 1.59

Kent Lake PR LLC 1.48

State Street Corp 1.30

American Century Companies Inc 1.26

Dimensional Fund Advisors, Inc. 1.14

Divisadero Street Capital Management, LP 1.03

Royce Small-Cap Opportunity Invmt 1.00

Oberweis Asset Management Inc 0.92

Renaissance Technologies Corp 0.91

Oberweis Micro-Cap 0.89

Oberweis Micro-Cap Growth 0.89

FTGF RY US SmCp Opp A USD Dis(A) 0.84

Avantis US Small Cap Value ETF 0.80

Vanguard Institutional Extnd Mkt Idx Tr 0.76

Kennedy Capital Management Inc 0.69

Fidelity Small Cap Index 0.67

Qube Research & Technologies 0.67

AQR Capital Management LLC 0.66

Eversept Partners, LP 0.64

Buckley Capital Advisors LLC 0.60

The Goldman Sachs Group Inc 0.58

iShares Russell 2000 Growth ETF 0.57

Fidelity Enhanced Small Cap ETF 0.55

Knights of Columbus Small Cap I 0.39

Knights Small Cap Core Equity 0.39

Kennedy Micro Cap 0.37

Fidelity Extended Market Index 0.36

State St Russell Sm/Mid Cp® Indx SL Cl I 0.35

Schwab US Small-Cap ETF™ 0.33

Vanguard Russell 2000 ETF 0.33

Kennedy Micro Cap Opportunities 0.31

Lazard US Small Cap Equity WW Dist EUR 0.31

Bioventus Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 1

Sell: 0

Strong Sell: 0

Bioventus Inc Fundamentals

Market Cap 582.06 M

PB Ratio 3.1652

PE Ratio 26.1818

Enterprise Value 825.45 M

Total Assets 683.56 M

Volume 692620

Bioventus Inc Company Financials

Annual Revenue FY23:502756000 502.8M, FY22:512117000 512.1M, FY21:430898000 430.9M, FY20:321161000 321.2M, FY19:340141000 340.1M

Annual Profit FY23:316081000 316.1M, FY22:331080000 331.1M, FY21:302706000 302.7M, FY20:233519000 233.5M, FY19:249206000 249.2M

Annual Net worth FY23:-182064000 -182.1M, FY22:-213391000 -213.4M, FY21:9586000 9.6M, FY20:16411000 16.4M, FY19:6851000 6.9M

Quarterly Revenue Q3/2025:138651000 138.7M, Q2/2025:147660000 147.7M, Q1/2025:123876000 123.9M, Q3/2024:138964000 139.0M, Q2/2024:151217000 151.2M

Quarterly Profit Q3/2025:92831000 92.8M, Q2/2025:102090000 102.1M, Q1/2025:83056000 83.1M, Q3/2024:93551000 93.6M, Q2/2024:101575000 101.6M

Quarterly Net worth Q3/2025:3155000 3.2M, Q2/2025:7459000 7.5M, Q1/2025:-2637000 -2.6M, Q3/2024:-4824000 -4.8M, Q2/2024:-23992000 -24.0M

About Bioventus Inc & investment objective

Company Information Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company's product portfolio includes pain treatments, which comprise various intra-articular and hyaluronic acid injections; peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the treatment of knee osteoarthritis; and Stimrouter to treat chronic peripheral pain, and TalisMann provides stimulation to the targeted peripheral nerve, as well as XCELL PRP System, a benchtop device that processes whole blood to produce high-yield PRP with a 10-minute single-spin cycle. It also offers precision bone resection for patients with degenerative spine conditions and spinal deformities, as well as enables precision ultrasonic neuro and general surgery to address brain tumors and pathologies of the liver and other organs; and bone graft substitutes, including various products that facilitate optimal bone fusion. In addition, the company provides neXus, an ultrasonic surgical system; BoneScalpel, a surgical solution enabling precise cuts in hard tissue; BoneScalpel Access, for bone removal with visualization; SonaStar system, a precise ablation and removal of soft tissue; SonaStar Elite handpiece and accessories; SonicOne, an ultrasonic cleansing and debridement system; Osteoamp, an allograft-derived bone graft for orthopedic, neurosurgical, and reconstructive bone grafting procedures; Signafuse bone graft; Purebone, a natural osteoconductive scaffold; and Reficio demineralized bone matrix. The company's restorative therapies include minimally invasive fracture treatments and rehabilitation products. Its products also include Exogen, an ultrasound bone stimulation system. The company sells its products to healthcare institutions, physicians, patients, distributors and dealers. Bioventus Inc. was founded in 2011 and is headquartered in Durham, North Carolina.

Organisation Medical Devices

Employees 930

Industry Medical Devices

CEO Mr. Robert E. Claypoole

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Bioventus Inc FAQs

What is the share price of Bioventus Inc today?

The current share price of Bioventus Inc is $8.46.

Can I buy Bioventus Inc shares in India?

Yes, Indian investors can buy Bioventus Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Bioventus Inc shares in India?

You can easily invest in Bioventus Inc shares from India by:

Can I buy fractional shares of Bioventus Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Bioventus Inc?

Bioventus Inc has a market cap of $582.06 M.

In which sector does Bioventus Inc belong?

Bioventus Inc operates in the Medical Devices sector.

What documents are required to invest in Bioventus Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Bioventus Inc?

The PE ratio of Bioventus Inc is 26.18 and the PB ratio is 3.17.